A precision therapeutic approach to study how COVID-19 affects the brain

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Hsieh Jenny

Frantz Douglas

Navara Christopher

Funded by

TBRI: San Antonio Partnership for Precision Therapeutics (SAPPT)

Research Start Date

01/01/2022

Status

Inactive

Basic Research

Collaborative Project

Basic Research

Disease Modeling

Genetics

Infectious Disease

Neuroscience

Bioscience Research Panel